MLL fusion proteins are resistant to ubiquitin‐proteasome‐mediated degradation due to the diminished interactions with E3 ligases Skp2 and Cdc20,37 leading to the stabilization and onset for MLL‐rearranged leukaemia. Here, KMT2A is linked to leukemia.